176 related articles for article (PubMed ID: 35177990)
21. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil.
Teixeira JJ; Crozatti MT; dos Santos CA; Romano-Lieber NS
PLoS One; 2012; 7(10):e47062. PubMed ID: 23071711
[TBL] [Abstract][Full Text] [Related]
22. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development.
Smelick GS; Heffron TP; Chu L; Dean B; West DA; Duvall SL; Lum BL; Budha N; Holden SN; Benet LZ; Frymoyer A; Dresser MJ; Ware JA
Mol Pharm; 2013 Nov; 10(11):4055-62. PubMed ID: 24044612
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia.
Bhagavathula AS; Berhanie A; Tigistu H; Abraham Y; Getachew Y; Khan TM; Unakal C
Asian Pac J Trop Biomed; 2014 May; 4(Suppl 1):S204-8. PubMed ID: 25183081
[TBL] [Abstract][Full Text] [Related]
25. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
Bossaer JB; Eskens D; Gardner A
J Oncol Pharm Pract; 2022 Jan; 28(1):82-86. PubMed ID: 33435823
[TBL] [Abstract][Full Text] [Related]
27. Prescribed Versus Taken Polypharmacy and Drug-Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study.
Anfinogenova ND; Novikova OM; Trubacheva IA; Efimova EV; Chesalov NP; Ussov WY; Maksimova AS; Shelkovnikova TA; Ryumshina NI; Stepanov VA; Popov SV; Repin AN
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568464
[TBL] [Abstract][Full Text] [Related]
28. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
29. Clinically important drug-drug interactions in primary care.
Dhabali AA; Awang R; Zyoud SH
J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
[TBL] [Abstract][Full Text] [Related]
30. Potential drug-drug interactions among hospitalized patients in a developing country.
Mousavi S; Ghanbari G
Caspian J Intern Med; 2017; 8(4):282-288. PubMed ID: 29201319
[TBL] [Abstract][Full Text] [Related]
31. Clinically significant drug interactions with antacids: an update.
Ogawa R; Echizen H
Drugs; 2011 Oct; 71(14):1839-64. PubMed ID: 21942976
[TBL] [Abstract][Full Text] [Related]
32. Study of drug-Drug interactions among the hypertensive patients in a tertiary care teaching hospital.
Subramanian A; Adhimoolam M; Kannan S
Perspect Clin Res; 2018; 9(1):9-14. PubMed ID: 29430412
[TBL] [Abstract][Full Text] [Related]
33. The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.
Xia H; Gao L; Gong X; Zaongo SD; Zhang T; Wu H; Ma P; Huang X
Front Pharmacol; 2020; 11():800. PubMed ID: 32536872
[TBL] [Abstract][Full Text] [Related]
34. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial.
Zerah L; Henrard S; Wilting I; O'Mahony D; Rodondi N; Dalleur O; Dalton K; Knol W; Haschke M; Spinewine A
BMC Geriatr; 2021 Oct; 21(1):571. PubMed ID: 34663238
[TBL] [Abstract][Full Text] [Related]
37. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
38. High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.
Busari AA; Oreagba IA; Oshikoya KA; Kayode MO; Olayemi SO
Niger Med J; 2019; 60(6):317-325. PubMed ID: 32180663
[TBL] [Abstract][Full Text] [Related]
39. Frequency, Predictors, and Outcomes of the Potential Drug-Drug Interactions in the ICUs of Teaching Hospitals in Ardabil, Northwest of Iran During 2019-2020.
Arab A; Sheikh-Germchi Z; Habibzadeh S; Sadeghiye-Ahari S; Mostafalou S
Hosp Pharm; 2023 Oct; 58(5):484-490. PubMed ID: 37711413
[No Abstract] [Full Text] [Related]
40. Potential determinants of prescribers' drug-drug interaction knowledge.
Ko Y; Malone DC; D'Agostino JV; Skrepnek GH; Armstrong EP; Brown M; Woosley RL
Res Social Adm Pharm; 2008 Dec; 4(4):355-66. PubMed ID: 19064242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
